Overview Single, Ascending Dose, First Time in Human Study for GZR18 in Healthy Subjects Status: Recruiting Trial end date: 2022-12-01 Target enrollment: Participant gender: Summary Single ascending dose first time in human study for GZR18 in healthy subjects Phase: Phase 1 Details Lead Sponsor: Gan and Lee Pharmaceuticals, USA